Clinical
Bruce S. Pyenson, FSA, MAAA, Gabriela Dieguez, FSA, MAAA, Christine Ferro, CHFP, Maushumi Mavinkurve, MPH, Yuri Sanchez Gonzalez, PhD
Importance of Health Outcomes Research for the Treatment of Hepatitis C Infection
Joseph Tkacz, MS, Michael P. Ingham, MSc, Brenna L. Brady, PhD, Roxanne Meyer, PharmD, Charles Ruetsch, PhD
Jacqueline Pesa, PhD, MPH, Roxanne Meyer, PharmD, Tiffany P. Quock, MS, PhD, Stacy K. Rattana, RN, BSN, Samir H. Mody, PharmD, MBA
Monitoring for Aberrant Opioid Utilization Patterns a Growing Need in Managed Care
Closing Gaps in Health Plan Performance with Stakeholder Collaboration
Value of Selecting the Best Antiemetic Prophylactic Agent for Patients Using Chemotherapy
Kelvin Lingjet Tran, DO, Young In Park, DO, Shalin Pandya, DO, Navin John Muliyil, DO, Brandon David Jensen, DO, Kovin Huynh, DO, Quang T. Nguyen, DO, FACE, FTOS
The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
Encouraging Compliance Key for Positive Outcomes in Schizophrenia/Chronic Diseases
Brent M. Tambourine, PharmD, BCPS, Arash Sadeghi, PharmD, Jianing Yang, MD, MS, Karen M. Stockl, PharmD, Heidi C. Lew, PharmD, Brian K. Solow, MD, FAAFP, Josephine N. Tran, PharmD, MS
